Letter to the EditorReply to: “Sorafenib efficacy for treatment of HCC recurrence after liver transplantation is an open issue”
Under a Creative Commons license
open access
Cited by (0)
© 2013 European Association for the Study of the Liver. Published by Elsevier B.V.